Aeovian Pharmaceuticals, Inc.

Jonathan Behr, a US partner at the Dementia Discovery Fund (DDF), sees the increase during the past few years in early-stage investments in neurodegeneration-focused biopharmaceutical companies having

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharma

This year's venture capital total as of the third quarter shows that money raised by biopharmaceutical companies is on a rollercoaster ride in 2019, according to the latest Venture Monitor report fr